Market revenue in 2023 | USD 83.9 million |
Market revenue in 2030 | USD 230.3 million |
Growth rate | 15.5% (CAGR from 2023 to 2030) |
Largest segment | Radiofrequency ablation |
Fastest growing segment | Other Ablation Technologies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation, Other Ablation Technologies |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Johnson & Johnson, AngioDynamics Inc, Bioventus Inc Class A, Edap TMS SA ADR, Mermaid Medical, Chongqing Haifu Technology, HealthTronics, H.S. Hospital Service |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tumor ablation market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 34.68% in 2023. Horizon Databook has segmented the China tumor ablation market based on radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, other ablation technologies covering the revenue growth of each sub-segment from 2018 to 2030.
China is the fastest-growing country in Asia Pacific and has a growing market due to increasing cancer cases and growing preference for safe & effective surgical ablation procedures. Many studies in China are adopting tumor ablation procedures as an alternative treatment to conventional surgical treatments, which is expected to boost market growth.
Thus, with increasing cases of cancer in the country, the need for better diagnostics and therapeutics is expected to boost the adoption of tumor ablation devices. In addition, favorable reimbursement scenarios and approval of new products are expected to drive the market.
Companies interested in entering China should recognize that they must overcome existing barriers in an ambiguous and changing regulatory environment. The country also offers high potential for the U.S. companies interested in expanding and entering into the tumor ablation market.
Horizon Databook provides a detailed overview of country-level data and insights on the China tumor ablation market , including forecasts for subscribers. This country databook contains high-level insights into China tumor ablation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account